Finance

Lists
Why is ERNAW down 17,14%?
Dive Deeper
ERNAW:NASDAQ
Ernexa Therapeutics Inc
USD 0,032
-17,14%
(-0,0066) 1D
2 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ERNAW...
Open
USD 0,05
High
USD 0,05
Low
USD 0,03
Mkt. cap
1,08 mjd
Avg. vol.
23,01 k
Volume
600,00
52-wk high
USD 0,23
52-wk low
USD 0,02
Open
USD 0,05
High
USD 0,05
Low
USD 0,03
Mkt. cap
1,08 mjd
Avg. vol.
23,01 k
Volume
600,00
52-wk high
USD 0,23
52-wk low
USD 0,02
News stories
From web sources and news partners
About Ernexa Therapeutics Inc
CEO-
Employees-
Founded1984
HeadquartersWilmington, Delaware, Verenigde State van Amerika
Sector-
Websiteblackrock.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reports
Loading Previous Earnings...
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme